IL6 and rheumatoid arthritis: IL-6 promotes the differentiation of Th17 cells and inhibits the differentiation of Treg cells (Tanaka et al., 2014); while IL-6 receptor antagonist reduces the inflammatory disease activity of RA (McInnes et al., 2015).